jueves, 7 de diciembre de 2017

Menopause - Dec 6, 2017 Edition

 
 December 6, 2017 
 Menopause 
 The latest menopause news from News Medical 
 Hot flashes may increase risk of developing diabetes, study suggestsHot flashes may increase risk of developing diabetes, study suggests
 
Hot flashes, undoubtedly the most common symptom of menopause, are not just uncomfortable and inconvenient, but numerous studies demonstrate they may increase the risk of serious health problems, including heart disease.
 
 
 BMI not valid measure of obesity in postmenopausal women, study showsBMI not valid measure of obesity in postmenopausal women, study shows
 
There is no doubt the prevalence of obesity has increased significantly across all age groups, creating greater health risks.
 
   Postmenopausal hormone therapy not linked to increased risk of strokePostmenopausal hormone therapy not linked to increased risk of stroke
 
Postmenopausal hormone therapy is not associated with increased risk of stroke, provided that it is started early, according to a report from Karolinska Institutet in Sweden published in the journal PLOS Medicine.
 
   Hyperhidrosis Prognosis and EpidemiologyHyperhidrosis Prognosis and Epidemiology
 
Hyperhidrosis refers to excessive sweating that does not necessarily occur in response to the body becoming overheated by exercise or a hot environment, for example. Although the condition does not pose any significant health risk, it can disrupt daily activities, causing embarrassment, stress, and sometimes even depression.
 
 Chronic preconception exposure to genistein may adversely affect female fertility, mice study finds
 
Chronic preconception exposure to genistein may adversely affect female fertility, mice study findsExposure to the phytoestrogen genistein prior to conception may adversely affect female fertility and pregnancy outcomes, depending on the dosage and duration of exposure, a new study in mice suggests.
 
 
 Hormone replacement therapy after ovary removal lowers risk of glaucoma, study finds
 
Hormone replacement therapy after ovary removal lowers risk of glaucoma, study findsWomen who took estrogen-only hormone replacement therapy after ovary removal had a lower risk of developing glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
 

No hay comentarios:

Publicar un comentario